Chemical Test Quickly Finds Cognitive Damage in Stroke Patients

Testing for three brain chemicals reveals impairment faster than standard neuropsychological exams

Join Our Community of Science Lovers!

A stroke happens when blood flow to the brain is interrupted and brain cells starve of oxygen. Aftereffects include muscle weakness and altered senses. In many cases, strokes also affect the way a patient thinks or processes information.

Quickly identifying the effects of a stroke helps doctors to tailor rehabilitation programs to the needs of a patient. Currently, structural neuroimaging and neuropsychological tests assess cognitive damage, but these take time and require the patient to be involved and compliant.

Now, a team led by Weizhong Wang and Xiaoying Bi from the Second Military Medical University in Shanghai has analysed metabolic changes following a stroke. The researchers were particularly interested in identifying changes related to post-stroke cognitive impairment. Bi explains that these changes may be ‘caused by inflammation, neurotoxicity or oxidative stress’ because of the stroke.

On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.

The team used paired ultra-high performance liquid chromatography and Q-TOF mass spectrometry to study serum samples from a control group, a post-stroke cognitively impaired group and a post-stroke non-cognitively impaired group of patients. Multivariate data analysis of the data set highlighted the different metabolic profiles of the groups and identified a wide range of metabolic changes.

To create a practical test, the team then used a regression model to pare down the metabolites to three that were simple to check for: glutamine—an amino acid; kynurenine—a metabolite of tryptophan; and lysoPC(18:2)—a lysophospholipid. These biomarkers can rapidly identify post-stroke cognitive impairment without actively involving the patient in the testing.

Peng Song, a specialist in neuro-analytical chemistry, from the Eastman Chemical Company in the US says the research signals the coming age of clinical metabolomics. ‘The finding paves the way for a better understanding of the molecular mechanisms and eventually, more effective treatment,’ he adds.

This article is reproduced with permission from Chemistry World. The article was first published on November 2, 2015.

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American